MNG Laboratories a portfolio company of HealthEdge has been sold to LabCorp
Client: Healthedge Investment Partners
Client Location: U.S.
Target: MNG Laboritories
Target Location: U.S.
Buyer: Laboratory Corporation of America
Buyer Location: U.S.
Target Description: MNG is a leading clinical diagnostic provider specializing in neurogenetic and complex biochemical testing.
Meet our Senior Team
View More Transactions in Healthcare
Lincoln International advised Olive AI on the sale of substantially all of its assets to Waystar and Humata Health
Lincoln International advised Scantox Group, a portfolio company of Impilo, on its acquisition of QPS Austria’s Neuropharmacology Division
Lincoln International advised HealthEdge Investment Partners on the sale of Corridor to WellSky, a portfolio company of Leonard Green and TPG Capital
Lincoln International advised Align Capital Partners on the sale of VetEvolve to Varsity Healthcare Partners
Lincoln International advised Havencrest Capital Management on its majority investment in Tekton Research
Lincoln International advised Your Way Medicare on its sale to Accretive, a portfolio company of GTCR
Lincoln International advised Seventure and minority shareholders on the sale of TargEDys to Biocodex
Lincoln International advised KPS Capital Partners on its sale of LRE Medical to Gyrus Capital
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.